SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response

Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset

(2021) Varun Sasisekharan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients

(2021) Allison N. Grossberg et al.   Nature Communications

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’

(2020) Enrico Lavezzo et al.   NATURE

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

(2020) Alberto L. Garcia-Basteiro et al.   Nature Communications

Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity.

(2020) Tyler J. Ripperger et al.   IMMUNITY

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

(2020) Diana Buitrago-Garcia et al.   PLOS MEDICINE

The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship

(2020) Jon C Emery et al.   eLife

Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report

(2020) Ourania E. Tsitsilonis et al.   Life-Basel

Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production

(2020) Yuezhou Chen et al.   CELL

Identification of Presymptomatic and Asymptomatic Cases Using Cohort-Based Testing Approaches at a Large Correctional Facility—Chicago, Illinois, USA, May 2020

(2020) Ashutosh Wadhwa et al.   CLINICAL INFECTIOUS DISEASES

High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris

(2020) François Anna et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

(2020) Eric A Meyerowitz et al.   LANCET INFECTIOUS DISEASES

Cytokine Storm

(2020) David C. Fajgenbaum et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Outbreak of Covid-19 on an Aircraft Carrier

(2020) Matthew R. Kasper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients

(2020) Anwar M. Hashem et al.   Viruses-Basel

Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China

(2020) Shiyi Cao et al.   Nature Communications

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

(2020) Kening Li et al.   Nature Communications

Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study

(2020) Evangelos Terpos et al.   Microorganisms

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study

(2020) Oon Tek Ng et al.   LANCET INFECTIOUS DISEASES